Drug-resistant "nightmare bacteria" cases increase in the United States

Cases of "nightmare bacteria," drug-resistant infections, have risen nearly 70% in the U.S. between 2019 and 2023. The increase is largely driven by bacteria with the NDM gene, which are resistant to most antibiotics, requiring expensive IV treatments. These once-rare infections are now appearing more frequently, potentially making common infections harder to treat and raising concerns about community spread.